CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 1/2, Open-label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03625037
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:00.452090+00:00
- Published At
- 2026-04-08T00:00:00+00:00
- Record Updated At
- 2026-04-08
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["DLBCL", "High-grade B-cell Lymphoma (HGBCL)", "Primary Mediastinal Large B-cell Lymphoma (PMBCL)", "FL", "MCL", "Small Lymphocytic Lymphoma (SLL)", "Marginal Zone Lymphoma (MZL)", "Indolent B-cell Non-Hodgkin Lymphoma (iNHL)", "Aggressive B-cell Non-Hodgkin Lymphoma (aNHL)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-08"- protocolSection.identificationModule.nctId
"NCT03625037"- protocolSection.identificationModule.officialTitle
"A Phase 1/2, Open-label Safety Trial of GEN3013 in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma"- protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.